|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Less: Loss from discontinued operations, net of tax | |||||
| (Loss) income from continuing operations | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities | |||||
| (Gain) loss on impairments and disposal of assets | |||||
| Amortization of intangibles | |||||
| Depreciation | |||||
| Non-cash compensation expense | |||||
| Deferred income taxes | |||||
| Change in fair value of contingent consideration | |||||
| Total change in fair value of contingent consideration | |||||
| Bad debt expense | |||||
| Amortization of debt issuance costs | |||||
| 2025 Convertible Notes | |||||
| Total amortization of debt issuance costs | |||||
| Write-off of previously-capitalized debt issuance costs | |||||
| 2025 Convertible Notes | |||||
| Total write-off of previously-capitalized debt issuance costs | |||||
| Amortization of debt discount | |||||
| Total amortization of debt discount | |||||
| Reduction in carrying amount of ROU asset, offset by change in operating lease liabilities | |||||
| Gain on settlement of convertible debt | |||||
| 2025 Convertible Notes | |||||
| Total gain on settlement of convertible debt | |||||
| Loss (gain) on investments | |||||
| Loss on impairment of equity investments | |||||
| Convertible Debt | |||||
| Secured Debt | |||||
| Impairment of long-lived assets | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid and other assets | |||||
| Accounts payable, accrued expenses and other current liabilities | |||||
| Income taxes receivable | |||||
| Other, net | |||||
| Net cash provided by operating activities attributable to continuing operations | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Capital expenditures | |||||
| Purchase of equity investment | |||||
| Proceeds from the sale of equity investment | |||||
| Proceeds from the sale of fixed assets | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Payments related to net-share settlement of stock-based compensation, net of proceeds from exercise of stock options | |||||
| Purchase of treasury stock | |||||
| Proceeds from term loan | |||||
| Repayment of term loan | |||||
| Payment of revolver issuance costs | |||||
| 2025 Convertible Notes | |||||
| Payment of debt issuance costs | |||||
| Payment of original issue discount on term loan | |||||
| Other financing activities | |||||
| Net cash used in financing activities | |||||
| Total cash (used in) provided by continuing operations | |||||
| Net cash provided by operating activities attributable to discontinued operations | |||||
| Net decrease in cash, cash equivalents, restricted cash and restricted cash equivalents | |||||
| Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period | |||||
| Cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period | |||||
| Non-cash investing activities: | |||||
| Increase (decrease) in capital expenditures included in accounts payable and accrued expenses | |||||
| Supplemental cash flow information: | |||||
| Income tax payments | |||||
| Income tax refunds | |||||
Loading...